Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum

Alder, 2010, Fate of [beta]-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland, Water Res., 44, 936, 10.1016/j.watres.2009.10.002 Ali, 2009, Chiral separation of β-adrenergic blockers on CelluCoat column by HPLC, Talanta, 78, 458, 10.1016/j.talanta.2008.11.043 Ali, 2009, Chiral analysis of ibuprofen residues in water and sediment, Anal. Lett., 42, 1747, 10.1080/00032710903060768 Andersson, 2003, Evaluation of generic chiral liquid chromatography screens for pharmaceutical analysis, J. Chromatogr. A, 1005, 83, 10.1016/S0021-9673(03)00888-4 Aranas, 2011, Sweeping–micellar electrokinetic chromatography for the simultaneous analysis of tricyclic antidepressant and β-blocker drugs in wastewater, Talanta, 85, 86, 10.1016/j.talanta.2011.03.032 Ates, 2008, Chiral separations in polar organic solvent chromatography: updating a screening strategy with new chlorine-containing polysaccharide-based selectors, J. Chromatogr. B, 875, 57, 10.1016/j.jchromb.2008.07.038 Barreiro, 2010, A column-switching method for quantification of the enantiomers of omeprazole in native matrices of waste and estuarine water samples, Talanta, 82, 384, 10.1016/j.talanta.2010.04.056 Benotti, 2009, Microbial degradation of pharmaceuticals in estuarine and coastal seawater, Environ. Pollut., 157, 994, 10.1016/j.envpol.2008.10.009 Berthod, 2009, Chiral recognition mechanisms with macrocyclic glycopeptide selectors, Chirality, 21, 167, 10.1002/chir.20600 Bioanalytical Method Validation: Guidance for Industry, 2001. US Food and Drug Administration. Borges, 2009, Enantioselective analysis of propranolol and 4-hydroxypropranolol by CE with application to biotransformation studies employing endophytic fungi, Electrophoresis, 30, 3910, 10.1002/elps.200900216 Bosáková, 2005, Comparison of vancomycin-based stationary phases with different chiral selector coverage for enantioselective separation of selected drugs in high-performance liquid chromatography, J. Chromatogr. A, 1088, 94, 10.1016/j.chroma.2005.01.017 Buchberger, 2011, Current approaches to trace analysis of pharmaceuticals and personal care products in the environment, J. Chromatogr. A, 1218, 603, 10.1016/j.chroma.2010.10.040 Buser, 1999, Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater, Environ. Sci. Technol., 33, 2529, 10.1021/es981014w Calisto, 2009, Psychiatric pharmaceuticals in the environment, Chemosphere, 77, 1257, 10.1016/j.chemosphere.2009.09.021 Christen, 2010, Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action, Aquat. Toxicol., 96, 167, 10.1016/j.aquatox.2009.11.021 Cleuvers, 2005, Initial risk assessment for three β-blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090 Detroyer, 2001, Quantitative structure-retention and retention–activity relationships of β-blocking agents by micellar liquid chromatography, J. Chromatogr. A, 912, 211, 10.1016/S0021-9673(01)00577-5 Escher, 2005, Screening test battery for pharmaceuticals in urine and wastewater, Environ. Toxicol. Chem., 24, 750, 10.1897/04-091R.1 Fernández, 2010, Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (Madrid, Spain) and a potential risk characterization, Sci. Total Environ., 408, 543, 10.1016/j.scitotenv.2009.10.009 Fono, 2006, Attenuation of wastewater-derived contaminants in an effluent-dominated river, Environ. Sci. Technol., 40, 7257, 10.1021/es061308e Fono, 2005, Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters, Environ. Sci. Technol., 39, 9244, 10.1021/es047965t Hashim, 2010, Enantiomeric fraction as an indicator of pharmaceutical biotransformation during wastewater treatment and in the environment—a review, Environ. Technol., 31, 1349, 10.1080/09593331003728022 Jelic, 2011, Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment, Water Res., 45, 1165, 10.1016/j.watres.2010.11.010 Kasprzyk-Hordern, 2010, Pharmacologically active compounds in the environment and their chirality, Chem. Soc. Rev, 39, 4466, 10.1039/c000408c Kasprzyk-Hordern, 2010, Enantiomeric analysis of drugs of abuse in wastewater by chiral liquid chromatography coupled with tandem mass spectrometry, J. Chromatogr. A, 1217, 4575, 10.1016/j.chroma.2010.04.073 Khetan, 2007, Human pharmaceuticals in the aquatic environment: a challenge to green chemisty, Chem. Rev., 107, 2319, 10.1021/cr020441w Kim, 2009, Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes), J. Toxicol. Sci., 34, 227, 10.2131/jts.34.227 Kümmerer, 2009, The presence of pharmaceuticals in the environment due to human use—present knowledge and future challenges, J. Environ. Manag., 90, 2354, 10.1016/j.jenvman.2009.01.023 Lao, 2012, Enantioselective degradation of warfarin in soils, Chirality, 24, 54, 10.1002/chir.21023 Lee, 2007, Determination of β-blockers and β2-agonists in sewage by solid-phase extraction and liquid chromatography-tandem mass spectrometry, J. Chromatogr. A, 1148, 158, 10.1016/j.chroma.2007.03.024 Liu, 2009, Photo-induced environmental depletion processes of b-blockers in river waters, Photochem. Photobiol. Sci., 8, 768, 10.1039/b817890a MacLeod, 2007, Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. A, 1170, 23, 10.1016/j.chroma.2007.09.010 MacLeod, 2010, Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments, Water Res., 44, 533, 10.1016/j.watres.2009.09.056 Madureira, 2009, Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography-ion trap tandem mass spectrometry, J. Chromatogr. A, 1216, 7033, 10.1016/j.chroma.2009.08.060 Madureira, 2010, Spatiotemporal distribution of pharmaceuticals in the Douro River estuary (Portugal), Sci. Total Environ., 408, 5513, 10.1016/j.scitotenv.2010.07.069 Martinez, 2009, Environmental pollution by antibiotics and by antibiotic resistance determinants, Environ. Pollut., 157, 2893, 10.1016/j.envpol.2009.05.051 Mascolo, 2010, Biodegradability of pharmaceutical industrial wastewater and formation of recalcitrant organic compounds during aerobic biological treatment, Bioresour. Technol., 101, 2585, 10.1016/j.biortech.2009.10.057 Matamoros, 2009, Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen, Chemosphere, 75, 200, 10.1016/j.chemosphere.2008.12.008 Matlin, 1994, HPLC with carbohydrate carbamate chiral phases: influence of chiral phase structure on enantioselectivity, Chirality, 6, 135, 10.1002/chir.530060214 Mompelat, 2009, Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water, Environ. Int., 35, 803, 10.1016/j.envint.2008.10.008 Nikolai, 2006, Stereoisomer quantification of the -blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. A, 1131, 103, 10.1016/j.chroma.2006.07.033 Pal, 2010, Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects, Sci. Total Environ., 408, 6062, 10.1016/j.scitotenv.2010.09.026 Patrick, 2011, First evidence for a stereoselective incorporation of nonylphenol diastereomers in soil-derived organo-clay complexes, Environ. Chem. Lett., 9, 293, 10.1007/s10311-011-0315-5 Pedrouzo, 2011, Presence of pharmaceuticals and hormones in waters from sewage treatment plants, Water Air Soil Pollut., 217, 267, 10.1007/s11270-010-0585-8 Perrin, 2002, Screening approach for chiral separation of pharmaceuticals: part II. Reversed-phase liquid chromatography, J. Chromatogr. A, 966, 119, 10.1016/S0021-9673(02)00746-X Perrin, 2002, Screening approach for chiral separation of pharmaceuticals: part I. Normal-phase liquid chromatography, J. Chromatogr. A, 947, 69, 10.1016/S0021-9673(01)01573-4 Piersma, 2009, Endocrine-disrupting chemicals in food Piram, 2008, Photolysis of β-blockers in environmental waters, Chemosphere, 73, 1265, 10.1016/j.chemosphere.2008.07.018 Ribeiro, 2012, Environmental fate of chiral pharmaceuticals: determination, degradation and toxicity, vol 2 Robinson, 2007, Modeling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers, Chemosphere, 66, 757, 10.1016/j.chemosphere.2006.07.047 Rosal, 2010, Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Res., 44, 578, 10.1016/j.watres.2009.07.004 Santos, 2010, Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment, J. Hazard. Mater., 175, 45, 10.1016/j.jhazmat.2009.10.100 Tong, 2011, Disposal practices for unused medications around the world, Environ. Int., 37, 292, 10.1016/j.envint.2010.10.002 Trautwein, 2008, Aerobic biodegradability of the calcium channel antagonist verapamil and identification of a microbial dead-end transformation product studied by LC-MS/MS, Chemosphere, 72, 442, 10.1016/j.chemosphere.2008.02.022 Validation of Analytical Procedures: Text and Methodology Q2(R1), 1996. International Conference on Harmonization, 〈http://private.ich.org/LOB/media/MEDIA417.pdf〉. Winkler, 2001, Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems, Water Res., 35, 3197, 10.1016/S0043-1354(01)00026-4